Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05822609 · ClinicalTrials.gov registry record · Phase 2

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

A Phase 2 study of Type 1 Diabetes and Diabetic Kidney Disease, sponsored by University of Washington.

Recruiting
Registry status
Phase 2
Development phase
60
Enrollment target
4
Study locations

NCT05822609 is a Phase 2 study of Type 1 Diabetes and Diabetic Kidney Disease that is actively recruiting participants, run by University of Washington. The registered enrollment target is 60 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05822609, a Phase 2 study of Type 1 Diabetes and Diabetic Kidney Disease, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
Phase 2
Development phase
60 participants
Enrollment target
4
Study locations

Study Summary

The primary objective of this study is to determine the effects of semaglutide on kidney oxygenation and function in type 1 diabetes. The secondary objective is to determine the glycemic effects and safety of semaglutide in type 1 diabetes.

Conditions Studied

Type 1 Diabetes Diabetic Kidney Disease

Interventions

  • OTHER Placebo
  • DRUG Semaglutide

Study Locations (4)

Washington

  • University of Washington - Seattle
  • Providence Sacred Heart Medical Center - Spokane

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Ontario

  • Toronto General Hospital, University Health Network - Toronto

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-04-05
Est. Completion 2026-06
Phase Phase 2

Sponsor

University of Washington

1,048 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05822609

The ClinicalTrials.gov registry entry for NCT05822609 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (93% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05822609 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Washington, Colorado, Ontario.

Frequently Asked Questions

What is clinical trial NCT05822609 about?

NCT05822609 is a clinical study titled "Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes". The primary objective of this study is to determine the effects of semaglutide on kidney oxygenation and function in type 1 diabetes. The secondary objective is to determine the glycemic effects and safety of semaglutide in type 1 diabetes.

What is the current status of trial NCT05822609?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2024-04-05. Estimated completion is 2026-06.

What conditions does trial NCT05822609 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Diabetic Kidney Disease.

What interventions are being tested in trial NCT05822609?

The interventions under investigation include: Placebo (OTHER), Semaglutide (DRUG).

Who is sponsoring clinical trial NCT05822609?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05822609 being conducted?

This trial has 4 study locations across Colorado, Washington, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 1 Diabetes

All registered trials for this condition

Diabetic Kidney Disease

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.